000 | 01949 a2200517 4500 | ||
---|---|---|---|
005 | 20250517202824.0 | ||
264 | 0 | _c20190423 | |
008 | 201904s 0 0 eng d | ||
022 | _a1525-0024 | ||
024 | 7 |
_a10.1016/j.ymthe.2018.01.019 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRicca, Jacob M | |
245 | 0 | 0 |
_aPre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy. _h[electronic resource] |
260 |
_bMolecular therapy : the journal of the American Society of Gene Therapy _c04 2018 |
||
300 |
_a1008-1019 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aAdaptive Immunity |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aGene Expression |
650 | 0 | 4 |
_aGenetic Therapy _xadverse effects |
650 | 0 | 4 |
_aGenetic Vectors _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections, Intralesional |
650 | 0 | 4 |
_aLymphocyte Activation _xgenetics |
650 | 0 | 4 | _aMelanoma, Experimental |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNeoplasms _ximmunology |
650 | 0 | 4 |
_aNewcastle disease virus _xgenetics |
650 | 0 | 4 |
_aOncolytic Virotherapy _xadverse effects |
650 | 0 | 4 |
_aOncolytic Viruses _xgenetics |
650 | 0 | 4 |
_aT-Lymphocyte Subsets _ximmunology |
650 | 0 | 4 | _aTransgenes |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aOseledchyk, Anton | |
700 | 1 | _aWalther, Tyler | |
700 | 1 | _aLiu, Cailian | |
700 | 1 | _aMangarin, Levi | |
700 | 1 | _aMerghoub, Taha | |
700 | 1 | _aWolchok, Jedd D | |
700 | 1 | _aZamarin, Dmitriy | |
773 | 0 |
_tMolecular therapy : the journal of the American Society of Gene Therapy _gvol. 26 _gno. 4 _gp. 1008-1019 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ymthe.2018.01.019 _zAvailable from publisher's website |
999 |
_c28120446 _d28120446 |